These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26288187)

  • 1. Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.
    Schnitzler F; Friedrich M; Stallhofer J; Schönermarck U; Fischereder M; Habicht A; Karbalai N; Wolf C; Angelberger M; Olszak T; Beigel F; Tillack C; Göke B; Zachoval R; Denk G; Guba M; Rust C; Grüner N; Brand S
    PLoS One; 2015; 10(8):e0135807. PubMed ID: 26288187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of inflammatory bowel disease in the organ recipient.
    Indriolo A; Ravelli P
    World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
    Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP
    Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients.
    Mohabbat AB; Sandborn WJ; Loftus EV; Wiesner RH; Bruining DH
    Aliment Pharmacol Ther; 2012 Sep; 36(6):569-74. PubMed ID: 22779779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
    Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
    J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation.
    Bortlik M; Duricova D; Machkova N; Hruba V; Lukas M; Mitrova K; Romanko I; Bina V; Malickova K; Kolar M; Lukas M
    Scand J Gastroenterol; 2016; 51(2):196-202. PubMed ID: 26329773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
    Wörns MA; Lohse AW; Neurath MF; Croxford A; Otto G; Kreft A; Galle PR; Kanzler S
    Am J Gastroenterol; 2006 Aug; 101(8):1931-7. PubMed ID: 16790037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
    Willot S; Noble A; Deslandres C
    Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and management of inflammatory bowel disease after liver transplantation.
    Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
    Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR; Malek-Hosseini SA; Sivandzadeh GR; Safarpour AR; Bagheri Lankarani K; Taghavi AR; Ejtehadi F
    Inflamm Bowel Dis; 2017 Jul; 23(7):1160-1167. PubMed ID: 28520586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
    Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
    Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Karmiris K; Bossuyt P; Sorrentino D; Moreels T; Scarcelli A; Legido J; Dotan I; Naismith GD; Jussila A; Preiss JC; Kruis W; Li AC; Bouguen G; Yanai H; Steinwurz F; Katsanos KH; Subramaniam K; Tarabar D; Zaganas IV; Ben-Horin S;
    J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).
    Eriksson C; Marsal J; Bergemalm D; Vigren L; Björk J; Eberhardson M; Karling P; Söderman C; ; Myrelid P; Cao Y; Sjöberg D; Thörn M; Karlén P; Hertervig E; Strid H; Ludvigsson JF; Almer S; Halfvarson J
    Scand J Gastroenterol; 2017; 52(6-7):722-729. PubMed ID: 28362144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Bowel Disease Patients Are at Increased Risk of Invasive Pneumococcal Disease: A Nationwide Danish Cohort Study 1977-2013.
    Kantsø B; Simonsen J; Hoffmann S; Valentiner-Branth P; Petersen AM; Jess T
    Am J Gastroenterol; 2015 Nov; 110(11):1582-7. PubMed ID: 26346865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
    Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory bowel disease in liver transplanted patients.
    Filipec Kanizaj T; Mijic M
    World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.